Hunt­ing for ‘cer­tain­ty and sta­bil­i­ty,’ WuXi Bio spot­lights client re­la­tion­ships

WuXi Bi­o­log­ics tout­ed its part­ner­ships and con­tracts in its an­nu­al re­port on Tues­day, not­ing that it has al­most 700 projects in its pipeline, which can help sup­ply the ser­vice provider with se­cu­ri­ty.

The stocks for both WuXi Bi­o­log­ics and its sis­ter com­pa­ny WuXi AppTec have yet to mean­ing­ful­ly re­cov­er since Jan­u­ary, when the draft of the BIOSE­CURE Act gained mo­men­tum. “In the face of un­cer­tain­ties, we are ded­i­cat­ed to find­ing cer­tain­ty and sta­bil­i­ty through our strate­gic ini­tia­tives,” CEO Chris Chen said in a press re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER